Alice Renard
Director/Board Member at Forcefield Therapeutics Ltd.
Network origin in Alice Renard first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
London School of Economics & Political Science
143
| College/University | Other Consumer Services | 143 |
Syncona Partners LLP
 Syncona Partners LLP Investment ManagersFinance Syncona Partners LLP (Syncona Partners) is a venture capital subsidiary of Syncona Investment Management Ltd. founded in 2012 by Martin Murphy. The firm is headquartered in London, United Kingdom.
31
| Subsidiary | Investment Managers | 31 |
Forcefield Therapeutics Ltd.
3
| Private Company | 3 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Alice Renard via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Private Equity Investor | |
| GILEAD SCIENCES, INC. | Biotechnology | Corporate Officer/Principal Director/Board Member | |
| 3I GROUP PLC | Investment Managers | Corporate Officer/Principal Comptroller/Controller/Auditor | |
Citigroup Global Markets Ltd.
 Citigroup Global Markets Ltd. Investment Banks/BrokersFinance Citigroup Global Markets Ltd. (CGML) is an international broker-dealer firm headquartered in London, UK. The firm was founded in 1983 and is a subsidiary of Citigroup Global Markets Holdings Bahamas Ltd., ultimately held by Citigroup, Inc. (NYSE: C) in the US. CGML has a major presence in the international financial markets as a dealer, market-maker and underwriter in equity and fixed income securities and offers risk-based solutions to producers and investors in commodity markets. They also provide corporate finance services to a wide range of corporate, institutional and government clients. Their trading activities encompass cash, exchange traded and OTC derivative markets. | Investment Banks/Brokers | Analyst-Equity Analyst-Equity | |
HgCapital LLP
 HgCapital LLP Investment ManagersFinance HgCapital LLP (HgCapital) is a private equity firm founded in 1985 by Craig M. Donaldson. The firm is headquartered in London, United Kingdom with additional offices in Munich, Paris, New York and San Francisco. | Investment Managers | Private Equity Investor Private Equity Investor | |
| SYNCONA LIMITED | Investment Trusts/Mutual Funds | Corporate Officer/Principal Chief Executive Officer Corporate Officer/Principal Private Equity Investor | |
| GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member | |
JPMorgan Asset Management (UK) Ltd.
 JPMorgan Asset Management (UK) Ltd. Investment ManagersFinance JPMorgan Asset Management (UK) Ltd. (JPMAM-UK) is the wholly owned, Great Britain-based investment arm of JPMorgan Asset Management International Ltd., ultimately held by JPMorgan Chase & Co. (NYSE: JPM) in the US. The firm was founded in 1974 and formerly known as JPMorgan Fleming Asset Management. They changed their name to JPMorgan Asset Management UK Ltd. in 2005. Headquartered in London, JPAM-UK provides investment advisory services to institutional clients, both US and non-US. | Investment Managers | Analyst-Fixed Income Portfolio Manager-Fixed Income | |
| Stanford University | College/University | Doctorate Degree | |
| University of Pennsylvania | College/University | Undergraduate Degree | |
| DECHRA PHARMACEUTICALS | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| University of Oxford | College/University | Undergraduate Degree Doctorate Degree Graduate Degree Graduate Degree | |
Cinven Group Ltd.
 Cinven Group Ltd. Investment ManagersFinance Cinven Group Ltd (Cinven Group) is a private equity firm founded in 1977. The firm is headquartered in London, United Kingdom. | Investment Managers | Private Equity Investor | |
| Imperial College London | College/University | Doctorate Degree Doctorate Degree | |
Scottish Equity Partners LLP
 Scottish Equity Partners LLP Investment ManagersFinance Scottish Equity Partners LLP (Scottish Equity Partners) is a private equity firm founded in 1991 by Gary de Vinchelez Le Sueur and Andrew S. Paterson. The firm is headquartered in London, the United Kingdom. | Investment Managers | Private Equity Investor Private Equity Investor | |
| University of Cambridge | College/University | Doctorate Degree Doctorate Degree Doctorate Degree Doctorate Degree Undergraduate Degree Doctorate Degree | |
| University of St. Gallen | College/University | Undergraduate Degree Undergraduate Degree | |
UBS AG (London Branch)
 UBS AG (London Branch) Investment ManagersFinance UBS AG (London Branch) is the Great Britain-based brokerage subsidiary of UBS AG, ultimately held by UBS Group AG (SWX: UBSG) in Switzerland. Headquartered in London, the firm was founded in 1998 and provides nimble, innovative and bespoke access to solutions, from market and insight tools, to trading strategies and execution for private, institutional and corporate clients worldwide, as well as private clients in Switzerland. They distribute, trade, finance and clear cash equity and equity-linked products. The firm also structures, originates and distributes new equity and equity-linked issues. | Investment Managers | Analyst-Equity Analyst-Equity | |
| The University of Nottingham | College/University | Undergraduate Degree Graduate Degree Undergraduate Degree | |
| University of Warwick | College/University | Undergraduate Degree Graduate Degree | |
| University College London | College/University | Undergraduate Degree Undergraduate Degree Graduate Degree | |
| University of Bocconi | College/University | Graduate Degree Undergraduate Degree | |
Mid Europa Partners LLP
 Mid Europa Partners LLP Investment ManagersFinance Mid Europa Partners LLP (Mid Europa Partners) is an independent private equity firm founded in 1999 by Thierry M. Baudon. The firm is headquartered in London. | Investment Managers | Private Equity Analyst Private Equity Investor | |
| Winchester College | College/University | Undergraduate Degree | |
| WHU-Otto Beisheim School of Management | College/University | Undergraduate Degree Graduate Degree | |
Bird Rock Bio, Inc.
 Bird Rock Bio, Inc. BiotechnologyHealth Technology Bird Rock Bio, Inc. develops protein therapeutics. It focuses on the discovery and development of novel antibodies with upsized potential that represent to antibody therapeutics. The company was founded by Richard J. Ulevitch, Phyllis Ellen Whiteley and Katherine S. Bowdish in 2007 and is headquartered in La Jolla, CA. | Biotechnology | Director/Board Member Director/Board Member | |
Savita Polymers Ltd.
 Savita Polymers Ltd. Industrial SpecialtiesProcess Industries Part of Savita Oil Technologies Ltd., Savita Polymers Ltd. is an Indian company that manufactures petroleum jelly, transformer and refrigeration oil. The company is based in Mumbai, India. Savita Polymers was acquired by Savita Oil Technologies Ltd. on October 08, 2021 for $16.63 million. | Industrial Specialties | Director/Board Member | |
| GANFENG LITHIUM GROUP CO., LTD. | Chemicals: Specialty | Corporate Secretary | |
| CEMS The Global Alliance in Management Education | College/University | Graduate Degree | |
Workstreampeople BV
 Workstreampeople BV Packaged SoftwareTechnology Services Workstreampeople BV engages in the development of microsoft centric intelligent dialogue management and cloud contact center platform. Its products include Anywhere365 Core, Anywhere365 WebAgent, Webchat Plus, Dialogue Intelligence for Power BI, Web Extension Window, and Inflight Snapper. The company was founded by Gijs Geurts and is headquartered in Rotterdam, the Netherlands. | Packaged Software | Director/Board Member | |
Resolution Therapeutics Ltd.
 Resolution Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Resolution Therapeutics Ltd. operates as a macrophage cell therapy company. The company was founded on December 14, 2017 and is headquartered in London, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Chairman Consultant / Advisor | |
SwanBio Therapeutics, Inc.
 SwanBio Therapeutics, Inc. BiotechnologyHealth Technology SwanBio Therapeutics, Inc. operates as a gene therapy firm. The company was founded by Tom Anderson, Rachel Salzman, Karen Kozarsky and Florian S. Eichler and is headquartered in Bala Cynwyd, PA. | Biotechnology | Chairman Chairman Director/Board Member | |
Blue Earth Diagnostics Ltd.
 Blue Earth Diagnostics Ltd. Medical/Nursing ServicesHealth Services Blue Earth Diagnostics Ltd. engages in the development and commercialization of positron emission tomography imaging agents. It focuses on the molecular imaging diagnostics. The company was founded in March 2014 and is headquartered in Oxford, the United Kingdom. | Medical/Nursing Services | Chairman Director/Board Member | |
OMass Therapeutics Ltd.
 OMass Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services OMass Therapeutics Ltd. develops native mass spectrometry platform The company was founded by Dame Carol Robinson and is headquartered in Oxford, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Autolus Ltd.
 Autolus Ltd. BiotechnologyHealth Technology Autolus Ltd. provides biopharmaceutical services. It focuses on the development and commercialisation of engineered t-cell immunotherapy products with extreme efficacy in the treatment of life-threatening cancers. The company was founded by Martin Pule and is headquartered in White City, the United Kingdom. | Biotechnology | Chairman Chief Executive Officer | |
| AUTOLUS THERAPEUTICS PLC | Biotechnology | Director/Board Member Director/Board Member | |
White & Case LLP (United Kingdom)
 White & Case LLP (United Kingdom) Miscellaneous Commercial ServicesCommercial Services Part of White & Case LLP, White & Case LLP (United Kingdom) is a legal services provider. The company is based in London, UK. Founded in 2006. | Miscellaneous Commercial Services | Corporate Officer/Principal General Counsel | |
Achilles Therapeutics UK Ltd.
 Achilles Therapeutics UK Ltd. BiotechnologyHealth Technology Achilles Therapeutics Ltd. operates as a biopharmaceutical company. The firm develops personalized vaccines and adoptive T cell therapies to treat metastatic cancer. It uses DNA sequencing data from each patient, together with a proprietary bioinformatics platform, to identify clonal neoantigens specific to that patient and enable the development of personalised cell therapies. The company was founded by Karl Peggs, Mark Lowdell, Charles Swanton and Sergio Quezada in May 2016 and is headquartered in London, the United Kingdom. | Biotechnology | Director/Board Member Corporate Officer/Principal | |
Anaveon AG
 Anaveon AG BiotechnologyHealth Technology Anaveon AG engages in the development of immune therapies against cancer. Its compounds promote effector T-cell functions to enhance a patient?s immune system to respond to tumors. The company was founded on December 11, 2017 by Onur Boyman and Andreas Katopodis and is headquartered in Bottmingen, Switzerland. | Biotechnology | Chairman Director/Board Member | |
Quell Therapeutics Ltd.
 Quell Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Quell Therapeutics Ltd. is a London-based biotechnology company, which develops immune cell therapies to target transplant rejection, autoimmune and inflammatory diseases. It develops engineered T regulatory cell therapies for a variety of non-cancer targets. The company was founded on March 19, 2019 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Azeria Therapeutics Ltd.
 Azeria Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Azeria Therapeutics Ltd. engages in the research and development of pharmaceutical products. It develops treatments for hormone resistance that targets breast and prostate cancer patients. The company was founded by Jason Carroll in 2017 and is headquartered in Cambridge, the United Kingdom. | Pharmaceuticals: Major | Chairman Director/Board Member | |
Neogene Therapeutics, Inc.
 Neogene Therapeutics, Inc. BiotechnologyHealth Technology Neogene Therapeutics, Inc. engages in the provision T cell therapies to treat cancer. The company was founded by Ton N. M. Schumacher and Carsten Linnemann and is headquartered in New York, NY. | Biotechnology | Director/Board Member Director/Board Member | |
Cathay Innovation SAS
 Cathay Innovation SAS Investment ManagersFinance Cathay Innovation SAS is a venture capital firm, a subsidiary of Cathay Capital Private Equity SAS founded in 2015 by Denis Barrier and Ming Po Cai. Cathay Innovation SAS is headquartered in Paris. | Investment Managers | Private Equity Investor Private Equity Investor | |
Purespring Therapeutics Ltd.
 Purespring Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Purespring Therapeutics Ltd. provides biotechnological research and experimental development services. The company was founded on April 1, 2020 and is headquartered in London, the United Kingdom. | Miscellaneous Commercial Services | Chairman Director/Board Member | |
Bregal Milestone LLP
 Bregal Milestone LLP Investment ManagersFinance Bregal Milestone LLP (Bregal Milestone) is a private equity and venture capital subsidiary of Bregal Investments LLP founded in 2018 by Jan Bruennler, Cyrus Shey and Philippe Lautenberg. The firm is headquartered in London, United Kingdom. | Investment Managers | Private Equity Investor | |
TCI Fund Management Ltd.
 TCI Fund Management Ltd. Investment ManagersFinance TCI Fund Management Ltd. (TCI) is the Great Britain-based alternative investment management subsidiary of TCI Fund Management (UK) Ltd., itself a subsidiary of The Children’s Investment Fund Management (Cayman) Ltd. in the Cayman Islands. The firm was founded in 2003 by Christopher Hohn. Headquartered in London, TCI manages their flagship, The Children’s Investment Master Fund and its two feeder funds. | Investment Managers | Analyst-Equity | |
GHO Capital Partners LLP
 GHO Capital Partners LLP Investment ManagersFinance GHO Capital Partners LLP (GHO Capital Partners) is a private equity firm founded in 2014 by Mireille G. Gillings, Dennis B. Gillings, Alan Browning MacKay, Michael Irvine Mortimer and Andrea Ponti. The firm is headquartered in London, United Kingdom. | Investment Managers | Private Equity Analyst |
Statistics
International
| United Kingdom | 31 |
| United States | 8 |
| Germany | 3 |
| Switzerland | 3 |
| France | 3 |
Sectoral
| Health Technology | 14 |
| Consumer Services | 14 |
| Finance | 13 |
| Commercial Services | 5 |
| Process Industries | 3 |
Operational
| Director/Board Member | 153 |
| Private Equity Investor | 80 |
| Undergraduate Degree | 77 |
| Graduate Degree | 58 |
| Corporate Officer/Principal | 50 |
Most connected contacts
| Insiders | |
|---|---|
| Martin Murphy | 33 |
| Ken Galbraith | 30 |
| Roel Bulthuis | 29 |
| Bryan Geoffrey Morton | 22 |
| Chris Hollowood | 18 |
| Hitesh Thakrar | 14 |
| Lisa Bright | 13 |
| Mary Beth Brosnihan | 12 |
| Chun Yue Cheung | 11 |
| Siddharth Gautam Mehra | 10 |
| John Tsai | 10 |
| Rolf Soderstrom | 10 |
| Edward Hodgkin | 10 |
| Andrea Calabro | 9 |
| John Kelting | 9 |
- Stock Market
- Insiders
- Alice Renard
- Company connections